Michael Jeffrey Abrams
Founder at Abdera Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael McElhaugh | M | 50 | 10 years | |
| Lana Janes | M | - |
Abdera Therapeutics, Inc.
 Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | - |
| Gilly Regev | M | - |
SaNOtize Research & Development Corp.
 SaNOtize Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services SaNOtize Research & Development Corp operates as a biotech company. The firm develops antimicrobial and immunomodulation technology to treat and prevent microbial infections, including drug resistant microbes. The company was founded by Gilly Regev and Chris Miller and is headquartered in Vancouver, Canada. | - |
| Bill Adams | M | 62 |
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | 14 years |
| Gordon McCauley | M | - |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | - |
| Richard Henriques | M | 68 | 10 years | |
| Krista McKerracher | F | - | 3 years | |
| Chris Miller | M | - |
SaNOtize Research & Development Corp.
SaNOtize Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services SaNOtize Research & Development Corp operates as a biotech company. The firm develops antimicrobial and immunomodulation technology to treat and prevent microbial infections, including drug resistant microbes. The company was founded by Gilly Regev and Chris Miller and is headquartered in Vancouver, Canada. | - |
| Lori Lyons-Williams | F | - |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | 2 years |
| Andrew J. Rae | M | - |
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada.
University of British Columbia
| 3 years |
| Glenn Ives | M | 62 | 3 years | |
| Keith Manchester | M | 55 | 9 years | |
| Terry Sumner | M | - |
University of British Columbia
| - |
| Billy Jong | M | - |
University of British Columbia
| - |
| Dylan Sidoo | M | 30 |
University of British Columbia
| - |
| Caroline MacCallum | M | - |
University of British Columbia
| - |
| Alan Mackworth | M | - |
University of British Columbia
| - |
| Randall Findlay | M | 73 |
University of British Columbia
| - |
| Douglas Harding Mitchell | M | 85 |
University of British Columbia
| 14 years |
| Mads Daugaard | M | - |
University of British Columbia
| - |
| Murray W. Goldberg | M | 61 |
University of British Columbia
| - |
| Julie Wagemakers | F | - |
University of British Columbia
| - |
| Julie Ovenell | F | - |
University of British Columbia
| - |
| Michael Hayden | M | 72 |
University of British Columbia
| 41 years |
| William Panenka | M | - |
University of British Columbia
| - |
| John Metras | M | - |
University of British Columbia
| - |
| Kathleen Leahy | F | - |
University of British Columbia
| - |
| Adriaan de Jager | M | - |
University of British Columbia
| - |
| Susan Danard | F | - |
University of British Columbia
| - |
| Deb Zehr | F | - |
University of British Columbia
| - |
| Brian Heathcote | M | - |
University of British Columbia
| - |
| Debbie Harvie | F | - |
University of British Columbia
| - |
| Sally Aitken | F | - |
University of British Columbia
| - |
| Matthew Evenden | M | - |
University of British Columbia
| - |
| Ed Putnins | M | - |
University of British Columbia
| - |
| Natasha Affolder | F | - |
University of British Columbia
| - |
| Karyn Magnusson | F | - |
University of British Columbia
| - |
| Shervin Teymouri | M | 42 |
University of British Columbia
| - |
| Anthony G. Phillips | M | - |
University of British Columbia
| - |
| David P. Tan | M | - |
University of British Columbia
| - |
| Chris Mattock | M | 74 |
University of British Columbia
| - |
| Neil Cashman | M | 72 |
University of British Columbia
| 19 years |
| R. Bustin | M | - |
University of British Columbia
| 45 years |
| Christopher W. J. Boatman | M | - |
University of British Columbia
| - |
| Kevin Smith | M | - |
University of British Columbia
| - |
| Wilfred A. Jefferies | M | 65 |
University of British Columbia
| - |
| Iain Cleator | M | - |
University of British Columbia
| - |
| Zeid Mohamedali | M | - |
University of British Columbia
| - |
| Wayne Savigny | M | - |
University of British Columbia
| - |
| Robert Cousland | M | - |
University of British Columbia
| - |
| Anil K. Mangal | M | - |
University of British Columbia
| - |
| Fiorella Kostoris | F | 79 |
Massachusetts Institute of Technology
| 44 years |
| Michael Hitch | M | - |
University of British Columbia
| 17 years |
| Elisabeth Maurer-Spurej | M | - |
University of British Columbia
| - |
| David Sidoo | M | 64 |
University of British Columbia
| 10 years |
| Daniel Pauly | M | - |
University of British Columbia
| 30 years |
| Benjamin Herring | M | - |
University of British Columbia
| - |
| Cheryl Wellington | M | - |
University of British Columbia
| - |
| J. David Litster | M | 85 |
Massachusetts Institute of Technology
| 41 years |
| John Shepherd | M | - |
University of British Columbia
| - |
| Manon Harvey | F | - |
University of British Columbia
| 5 years |
| George Wesley Poling | M | 89 |
University of British Columbia
| 56 years |
| Bernhard Klein | M | 65 |
University of British Columbia
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark J. Murray | M | 75 |
Protiva Biotherapeutics, Inc.
 Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | 19 years |
| Paul Brennan | M | - |
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | 14 years |
| Ken Galbraith | M | 61 |
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | 5 years |
| Ronald Ian Lennox | M | 71 |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | 6 years |
| Elizabeth Howard | M | 70 | 7 years | |
| Vivek Ramaswamy | M | 38 | 3 years | |
| James DeMesa | M | 66 |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 7 years |
| Yoo-Hwan Jang | M | 69 |
Massachusetts Institute of Technology
| 3 years |
| Timothy M. Ruane | M | 59 | 3 years | |
| Donald Jewell | M | - |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | 14 years |
| Ernest Shingyan Wong | M | 56 | 1 years | |
| Ian MacLachlan | M | - |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | 14 years |
| Mark A. Clements | M | - |
Massachusetts Institute of Technology
| 3 years |
| Barbara Poggiali | M | 61 |
Massachusetts Institute of Technology
| 5 years |
| On-kwok Li | M | 69 |
Massachusetts Institute of Technology
| 3 years |
| Mark Gus Alexandridis | M | 66 |
Massachusetts Institute of Technology
| 6 years |
| Camilo Gomez | M | - |
Massachusetts Institute of Technology
| 8 years |
| Morris Kesler | M | - |
Massachusetts Institute of Technology
| 4 years |
| Henry Hoppe | M | - |
Massachusetts Institute of Technology
| 7 years |
| Mark Jennings | M | 63 |
Massachusetts Institute of Technology
| 5 years |
| Brian Eric Thompson | M | - |
Massachusetts Institute of Technology
| 5 years |
| Sahba S. Vaziri | F | - |
Massachusetts Institute of Technology
| 6 years |
| Gregg Burgess | M | - |
Massachusetts Institute of Technology
| 5 years |
| Jocelyn E. Scott | F | - |
Massachusetts Institute of Technology
| 4 years |
| Jerry L. Prince | M | - |
Massachusetts Institute of Technology
| 8 years |
| Beth A. Marcus | M | - |
Massachusetts Institute of Technology
| 5 years |
| Kei Yamamoto | F | - |
Massachusetts Institute of Technology
| 5 years |
| Ford Tamer | M | 62 |
Massachusetts Institute of Technology
| 5 years |
| Brian Daniels | M | 65 |
Massachusetts Institute of Technology
| 4 years |
| John A. DeTore | M | - |
Massachusetts Institute of Technology
| 7 years |
| Mike McElroy | M | - |
Massachusetts Institute of Technology
| 9 years |
| Anita Killian | F | - |
Massachusetts Institute of Technology
| 5 years |
| Sameer Gandhi | M | 58 |
Massachusetts Institute of Technology
| 15 years |
| Elizabeth Marie Robinson | M | - |
Massachusetts Institute of Technology
| 4 years |
| John Robert Chisholm | M | - |
Massachusetts Institute of Technology
| 7 years |
| Zaurie Zimmerman | F | - |
Massachusetts Institute of Technology
| 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 66 | 66.67% |
| United States | 39 | 39.39% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Jeffrey Abrams
- Personal Network
